Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

IL-17 Signaling Pathway Assay (CAT#: STEM-MB-0354-WXH)

Introduction

IL-17 is the main effector produced by Th17 cells and is essential for processes including host defense, tissue repair, pathogenesis of inflammatory diseases, and cancer progression. IL-17 can induce a variety of cells to release pro-inflammatory factors and neutrophil chemokines to adjust local tissue inflammation, and play an important role in the immune regulatory network. It has been proven to be related to asthma, tuberculosis, lung cancer and coronary arteries. Many diseases are related. The innate immune cells that produce IL-17 mainly include lymphoid tissue induced cells, natural killer cells, CD3+ stable natural killer T cells, γδT cells and myeloid cells. In addition, mast cells and neutrophils can also produce IL-17.




Principle

IL-17 can activate downstream signaling pathways shared by other cytokines, including NF-κB, mitogen-activated protein kinase, c-Jun N-terminal kinase, CCAAT/enhancer binding protein, phosphoinositide 3-kinase, p38 and cellular External signal-regulated kinases and so on. At the same time, it plays an important regulatory role in the stability of mRNA.

Applications

To study the effect of each virus on IL-17 signaling pathway
To study the regulation mechanism of IL-17 signal pathway in disease
To study the effects of drugs or therapies on IL-17 signaling pathways

Procedure

• Luminex Multiplex Assay
• Enzyme-linked immunosorbent assay (ELISA)
• Flow cytometry (FACS analysis) technology

Notes

Detectable targets: ACT1, TRAF2, TRAF3, TRAF4, TRAF5, TRAF6, TBK1, HSP90, MAP3K7, USP25, ELAVL1, IKK, IKB, JNK, AP-1, TAB1, TAB2, ERK1, ERK3, GSK3B, TRADD, FADD, Caspase, CEBPB, MKK, NF-kB, CEBP, p38, SRSF1

Other recommended products